“New Medications and FDA Updates 2016”
Event Navigation
HealthTrust presents…
“New Medications and FDA Updates 2016”
Download a PDF copy of this presentation. Download a recording of this presentation.
In 2016, there were 22 new molecular entities approved by the FDA for use in the United States, along with a number of FDA drug safety alerts released. This presentation will take an in-depth look at the selection of medications, studies that lead to approval, dosing and adverse effects, helping pharmacists gain proficiency in these new medications and bettering their daily practice. Other topics addressed will include FDA warnings and how they affect pharmacy practice, relating new medications approved in 2016 with those previously approved, and patient counseling and monitoring of the newly approved medications.
Learning Objectives:
- List medications that were brought to the market in 2016
- Identify drug safety warnings that were published by the FDA in 2016
- Describe the indications and mechanisms of action of the new medications
- Identify adverse effects for new medications
Presenter:
Suzannah Kokotajlo, PharmD, Pediatric Clinical Pharmacist, Goryeb Children’s Hospital
Target audience: Pharmacy
Continuing Education Credit:
- Pharmacy: Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-17-024-L01-P. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists who attend the webinar and complete the online evaluation.
